3 Trends Shaping Drug Development And Manufacturing Strategies

As treatments continue to grow in complexity and global demand for drug products rises, pharmaceutical companies must continue to innovate to ensure the safe, effective, and affordable manufacture of medicines. The rising demand for pharmaceuticals in Asia is putting pressure on companies to ensure their go-to-market strategies are informed by a clear understanding of the different regulatory and economic landscapes of the areas they are operating in - whether they be in Asia-Pacific, North American, or European markets.

Advancements in the biopharmaceutical space is also evolving the manufacturing dynamic in the industry. Varying company sizes and manufacturing requirements means that manufacturers must ensure they are equipped with the expertise and infrastructure to handle highly complex small batch sizes.

Innovators must strengthen their business models to manage higher costs of development and lengthened timelines. To overcome these challenges, companies are turning to strategic CDMO partnerships to harness the additional resources and capabilities they provide. Review the trends shaping the industry in the coming year and how partnering with a CDMO can help companies navigate the path to commercialization.